Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda

Go back to Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda
(NASDAQ: KROS) Delayed: 11.40 +0.12 (1.06%)
Previous Close $11.28    52 Week High $ 
Open $11.24    52 Week Low $ 
Day High $11.46    P/E N/A 
Day Low $11.20    EPS $ 
Volume 59,710